{
  "id": 171152,
  "title": "CVS blows past estimates, hikes guidance as insurance unit continues to improve",
  "url": "https://urgent.news/2026/08/05/cvs-blows-past-estimates-hikes-guidance-as-insurance-unit-continues",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-05T10:59:02.000Z",
  "source": {
    "name": "CNBC",
    "slug": "cnbc",
    "url": "https://www.cnbc.com/2026/08/05/cvs-health-cvs-earnings-q2-2026.html"
  },
  "original_language": "en",
  "account": "CVS Health exceeded expectations in its second-quarter earnings and projected revenue, as its insurance unit Aetna showed signs of improvement. The company now anticipates full-year adjusted earnings between $7.90 and $8.10 per share, an increase from the previous range of $7.30 to $7.50 per share. Additionally, CVS expects at least $414 billion in revenue for 2026, surpassing its earlier prediction of $405 billion. The higher profit guidance is attributed to gains in the company's insurance and retail pharmacy divisions, although CVS maintains a \"cautious view\" for the subsequent quarters due to high medical costs and potential economic challenges.\n\nCVS' insurance business, Aetna, demonstrated a positive trend with a medical benefit ratio of 87.4% in the second quarter, down from 89.9% in the previous year. This reduction signifies that the company collected more premiums than it paid out in benefits, resulting in increased profitability. The unit's revenue grew by 3.5% year-over-year to $37.54 billion, exceeding analysts' expectations of $35.66 billion. Aetna's medical membership remained steady at 26 million as of June 30, closely aligning with the March 31 figure.\n\nCVS' pharmacy and consumer wellness division reported $33.82 billion in revenue for the quarter, slightly higher than the prior year's $33.16 billion. Analysts had anticipated sales of $33.16 billion. The health services segment generated $51.8 billion in revenue for the quarter, an 11.5% increase compared to the same period last year. This segment encompasses the pharmacy benefits manager Caremark, which negotiates drug discounts, manages formularies, and reimburses pharmacies for prescriptions.",
  "summary": "CVS also announced a new collaboration with Eli Lilly that will make Zepbound and Foundayo accessible to eligible patients on the CVS Health app.",
  "key_points": [
    "CVS beats Q2 estimates with $7.90-$8.10 per share guidance",
    "Aetna's medical benefit ratio improves to 87.4%, up from 89.9%",
    "Revenue forecast for 2026 rises to $414 billion, up from $405 billion"
  ],
  "editors_take": null,
  "illustration": "https://urgent.news/ill/171152.png",
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}